Phosphoprotein enriched in astrocytes (PEA)-15 is a novel regulator of adipose tissue expansion
暂无分享,去创建一个
J. Ramos | G. Nixon | J. Rochford | A. Leeson-Payne | M. Delibegović | Fiona H. Greig | Pola Verschoor | Giovanni Levate | D. Thompson | Ruta Dekeryte | Ruth Banks | R. Dekeryte
[1] C. Kahn,et al. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. , 2019, The Journal of clinical investigation.
[2] P. Formisano,et al. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications , 2019, International journal of molecular sciences.
[3] Ji-Eun Lee,et al. Transcriptional and Epigenomic Regulation of Adipogenesis , 2019, Molecular and Cellular Biology.
[4] P. Scherer,et al. Adipogenesis and metabolic health , 2019, Nature Reviews Molecular Cell Biology.
[5] W. Han,et al. Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy , 2019, Disease Models & Mechanisms.
[6] I. C. Nettore,et al. High-fat diet unveils an enhancer element at the Ped/Pea-15 gene responsible for epigenetic memory in skeletal muscle. , 2018, Metabolism: clinical and experimental.
[7] J. Després,et al. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. , 2018, Progress in cardiovascular diseases.
[8] Amir I. Mina,et al. Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes , 2018, Molecular metabolism.
[9] J. Després,et al. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. , 2018, Circulation.
[10] K. Suchacki,et al. Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease , 2018, Molecular metabolism.
[11] J. Ramos,et al. PEA‐15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia , 2017, Journal of the American Heart Association.
[12] F. Schick,et al. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. , 2017, Cell metabolism.
[13] P. Whitfield,et al. Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE−/− mouse model of atherosclerosis with alterations in IL10/AMPKα pathway , 2017, Molecular metabolism.
[14] Matthew J. Potthoff,et al. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms. , 2017, Cell metabolism.
[15] P. Scherer,et al. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. , 2017, The Journal of clinical investigation.
[16] J. Tomlinson,et al. Non-alcoholic fatty liver disease and diabetes , 2016, Metabolism: clinical and experimental.
[17] S. Blair,et al. Obesity and Cardiovascular Disease , 2006 .
[18] T. McLaughlin,et al. Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans , 2016, Diabetes.
[19] Lihua Zhou,et al. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans , 2015, Adipocyte.
[20] P. Scherer,et al. The cell biology of fat expansion , 2015, The Journal of cell biology.
[21] G. Nixon,et al. Phosphoprotein enriched in astrocytes (PEA)-15: A potential therapeutic target in multiple disease states , 2014, Pharmacology & therapeutics.
[22] A. Wierzbicki,et al. Nonalcoholic fatty liver disease and lipids , 2012, Current opinion in lipidology.
[23] A. Sherman,et al. The Size of Large Adipose Cells Is a Predictor of Insulin Resistance in First‐Degree Relatives of Type 2 Diabetic Patients , 2012, Obesity.
[24] E. White,et al. PEA-15 potentiates H-Ras mediated epithelial cell transformation through Phospholipase D , 2011, Oncogene.
[25] A. Xu,et al. Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes* , 2011, The Journal of Biological Chemistry.
[26] J. Ramos,et al. A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells. , 2011, Cardiovascular research.
[27] S. Pastorino,et al. The death effector domain protein PEA‐15 negatively regulates T‐cell receptor signaling , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] A. Vidal-Puig,et al. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.
[29] G. Perruolo,et al. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. , 2009, American journal of physiology. Endocrinology and metabolism.
[30] P. Libby,et al. Obesity, inflammation, and atherosclerosis , 2009, Nature Reviews Cardiology.
[31] Y. Huang,et al. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. , 2009, Developmental cell.
[32] J. Ramos,et al. Death Effector Domain-Containing Proteins , 2009, Cellular and Molecular Life Sciences.
[33] A. Vidal-Puig,et al. Adipose tissue expandability and the metabolic syndrome , 2007, Genes & Nutrition.
[34] G. Shulman,et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.
[35] A. Tuzcu,et al. The correlation between adiposity and adiponectin, tumor necrosis factor α, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? , 2007, Journal of endocrinological investigation.
[36] Herbert Tilg,et al. Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.
[37] C. Dani,et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. , 2005, Diabetes.
[38] C. Lelliott,et al. ETO/MTG8 Is an Inhibitor of C/EBPβ Activity and a Regulator of Early Adipogenesis , 2004, Molecular and Cellular Biology.
[39] G. Troncone,et al. Overexpression of the ped/pea-15 Gene Causes Diabetes by Impairing Glucose-Stimulated Insulin Secretion in Addition to Insulin Action , 2004, Molecular and Cellular Biology.
[40] E. Formstecher,et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. , 2001, Developmental cell.
[41] R. Muise-Helmericks,et al. Signal transduction and the Ets family of transcription factors , 2000, Oncogene.
[42] P. Arner,et al. Regional differences in the control of lipolysis in human adipose tissue. , 1979, Metabolism: clinical and experimental.
[43] J. Ramos. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. , 2008, The international journal of biochemistry & cell biology.
[44] A. G. Shaper,et al. Obesity and cardiovascular disease. , 1996, Ciba Foundation symposium.
[45] K. Johnson. An Update. , 1984, Journal of food protection.